TY  - JOUR
AU  - Rodríguez Nogales, Carlos
AU  - Garbayo, E.
AU  - Martínez-Valbuena, I.
AU  - Sebastián, V.
AU  - Luquin, M.R.
AU  - Blanco-Prieto, M.J.
PY  - 2016
DO  - 10.1016/j.ijpharm.2016.06.044
SN  - 0378-5173
UR  - https://hdl.handle.net/20.500.14352/132810
T2  - International Journal of Pharmaceutics
AB  - Polo like kinase 2 (PLK2), a serine/threonine serum inducible kinase, has been proposed to be the major factor responsible for phosphorylating alpha-synuclein (α-syn) at Serine-129 (Ser-129) in Parkinson’s disease (PD). A suitable strategy to gain...
LA  - eng
M2  - 142
PB  - Elsevier
KW  - Polo-like kinase 2
KW  - Alpha-synuclein
KW  - Phosphorylation
KW  - Nanoparticles
KW  - PLGA
KW  - TROMS
TI  - Development and characterization of polo-like kinase 2 loaded nanoparticles-A novel strategy for (serine-129) phosphorylation of alpha-synuclein
TY  - journal article
VL  - 514
ER  -